Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0000899243-20-026411

Options or other derivatives

  • Director acquired 25,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Drutz David Director 2020-09-24 Grant or award · Stock Options (option to buy) +25,500 25,500 D: show line 1 in the form
Loading xslF345X03/doc4.xml…